(Q36968308)

17 August 2017

1 reference

title

Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine (English)

1 reference

17 August 2017

0 references

1

Hanne Nøkleby

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Expert Review of Vaccines

17 August 2017

published in

1 reference

17 August 2017

volume

6

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

863-869

1 reference

Childhood vaccine development: an overview

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

The Cutter incident, 50 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Vaccination against whooping-cough. Efficacy versus risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Permanent brain damage and pertussis vaccination: is the end of the saga in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Neurological adverse events associated with vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Guillain-Barré syndrome following influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Guillain-Barré syndrome following administration of live measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Hepatitis B vaccination and the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Mechanisms of stimulation of the immune response by aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

The global impact of vaccines containing aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Childhood macrophagic myofasciitis-consanguinity and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Applications of influenza virosomes as a delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Methods of ensuring vaccine safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

The Brighton Collaboration: enhancing comparability of vaccine safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

Time trends in autism and in MMR immunization coverage in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

How can doctors communicate information about risk more effectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.863

21 January 2018

Identifiers

DOI

10.1586/14760584.6.5.863

1 reference

17 August 2017

1 reference